Gelonghui, March 15, 丨 Superstar Medical Holdings (02393.HK) announced that compared to the Group's audited net loss of approximately RMB 1.02 billion for the year ended December 31, 2022, the Group expects a sharp reduction in fiscal year 2023 and recorded a net loss of no more than RMB 10 million.
The Group expects a sharp decrease in net losses in fiscal year 2023 mainly due to (i) a sharp reduction in impairment losses on goodwill and other intangible assets in fiscal year 2023; (ii) impairment losses on the return of some financial assets; and (iii) a sharp drop in financial costs.